Outcome of Renal Transplantation in Patients with Non–Shiga Toxin–Associated Hemolytic Uremic Syndrome: Prognostic Significa
![PDF) Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry | F. Manoni, M. Pradella, and Nicola Bizzaro - Academia.edu PDF) Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry | F. Manoni, M. Pradella, and Nicola Bizzaro - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/45680100/mini_magick20190211-29080-ihpk2e.png?1549917510)
PDF) Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry | F. Manoni, M. Pradella, and Nicola Bizzaro - Academia.edu
![PDF) A Particular Mutational Status in a Chronic Mieloid Leukemia Patient Treated with Different Tirosin-Kinase Inhibitors | Rosanna Ciancia and Claudio Cerchione - Academia.edu PDF) A Particular Mutational Status in a Chronic Mieloid Leukemia Patient Treated with Different Tirosin-Kinase Inhibitors | Rosanna Ciancia and Claudio Cerchione - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/46178833/mini_magick20220703-27679-19jydff.png?1656856887)